Chapter 440: Elena

Max sent the Ruth Albright file at ten PM Tuesday.

Forty-two pages. Eighteen years of regulatory architecture research documented cleanly. Four published books, twelve peer-reviewed papers, three policy briefs that had been cited in actual regulatory reform proceedings in two countries.

Sean read it until midnight.

He closed it with one thought.

She had been working on the same problem from the regulatory angle for longer than he had been working on it from any angle.

He would meet her Thursday.

He put the file away and went to sleep.

—

Wednesday was Richard’s follow-up appointment at Northern Research Hospital.

Sean had not planned to be there.

He was there anyway.

Not in the appointment. In the corridor outside the trial unit, reading the Ruth Albright file again on his phone, having arrived thirty minutes before Richard’s appointment because the hospital was between the campus and Alderton Street where he had a three PM with Clara, and the detour was fourteen minutes.

He told himself that.

It was partly true.

He was reading the file when footsteps came down the corridor from the trial unit direction.

He looked up.

A woman. Thirty-two. Five foot four. Korean-American. The specific precise build of someone who operated efficiently in everything. Dark hair cut short and practical. Dark eyes with the focused quality of someone who had been running a high-stakes research program for three years and who had learned to read everything in a room in the first pass.

She was carrying a tablet and a folder and moving at the pace of someone who had three things to get to before this hallway was done.

She registered him.

She slowed.

She looked at the tablet.

She looked at him.

"You’re not a patient," she said.

"No," he said.

"You’re not family of a patient," she said. "Family wait in the family room."

"I’m reading," he said.

She held the tablet.

She looked at him with the full version of the dark eyes.

"You’re here for the Miller patient," she said. Not a question.

He held her gaze.

"Richard Miller," she said. "The exception cohort addition. The family history feature." She held the tablet. "I’m the principal investigator on this trial. I know every patient’s profile."

He held her gaze.

"Yes," he said.

She held the tablet.

"You’re not family," she said. "His records show one daughter."

"No," he said. "I’m not family."

She looked at him.

"You’re the reason he was enrolled," she said.

He held her gaze.

"The clinical data—" he said.

"Supported his inclusion," she said. "I know. I reviewed the data. The data was genuinely strong." She held his gaze. "It was also presented to Thomas Reeve through the foundation’s board in a way that made the case impossible to decline." A pause. "I’ve been in research for twelve years. I know the difference between data that arrives and data that’s been placed."

He held her gaze.

"Dr. Park," he said.

She looked at him.

"How do you know my name," she said.

"I read the trial’s published methodology," he said. "Your name is on it."

"The dosing variance in phase two isn’t in the published methodology," she said.

He held her gaze.

She held his.

"You referenced it correctly in Max’s notes," she said. "I saw the background documentation when the foundation board reviewed the exception request."

"You saw Max’s notes," he said.

"I saw the supporting file," she said. "Whoever prepared it read the full trial documentation including the unpublished phase two parameters." She held the tablet. "That’s not a family member. That’s someone who does their research."

He held her gaze.

She held his.

"Are you the reason he was enrolled," she said.

He held her gaze for a moment.

"The data supported his inclusion," he said.

She held his gaze.

"Yes," she said. "It did." A pause. "And someone made sure it reached the right person at the right board meeting."

He said nothing.

She looked at him for a long moment with the full version of the focused dark eyes.

"I’m Elena Park," she said.

"Sean Miller," he said.

She held her tablet.

"You know about the dosing variance in phase two," she said.

"Yes," he said.

"And the family history feature demographic gap," she said.

"Yes," he said.

"You read the full trial documentation including the unpublished parameters," she said.

"Max organized the research literature," he said.

"Who is Max," she said.

"Someone thorough," he said.

She held the tablet.

She looked at him.

"You’re a student," she said. "Caldwell University. First year."

"Yes," he said.

"You’re eighteen years old," she said.

"Yes," he said.

"You arranged a board exception to a closed trial enrollment at a major research hospital," she said. "And you read the full technical documentation for the trial including parameters that aren’t publicly available." She held his gaze. "And you’re standing in a corridor at Northern Research Hospital on a Wednesday afternoon reading something on your phone."

"The Ruth Albright file," he said.

She held her tablet.

"Ruth Albright," she said.

"Director of the Independent Institute for Regulatory Architecture Research," he said. "Eighteen years of work on structural implementation failures in regulatory frameworks."

She held the tablet.

"I know who Ruth Albright is," she said. "I’ve read four of her papers."

"The 2019 paper on pathway failure in complex systems is the strongest," he said.

She held his gaze.

"That’s not a widely cited paper," she said.

"It should be," he said. "The mechanism she identified in the 2019 paper is the same one in Nadia Cross’s movement disorder research and in Diana Kellerman’s policy architecture framework."

She held her tablet.

She looked at him with the specific quality of someone who had found something that did not fit their existing categories and was deciding what to do with it.

"Nadia Cross," she said. "She co-authored a fellowship submission with Kellerman."

"Yes," he said.

"I read the preliminary framework," she said. "Kellerman sent it to the trial’s funding board last month. I read it." She held his gaze. "The fourth domain. Movement disorder pathway failures as a structural architecture failure."

"Nadia’s section," he said.

"It was excellent," she said. "It described the mechanism in movement disorder research more accurately than anything I’ve read in the clinical literature." She held his gaze. "Are you connected to that submission."

He held her gaze.

"It’s a fellowship submission supervised by Professor Kellerman," he said.

"That’s not an answer," she said.

He held her gaze.

"Yes," he said. "I’m connected to it."

She held his gaze for a long moment.

Then she looked at her tablet.

She looked at her watch.

She looked back at him.

"I have four minutes before my next patient consult," she said. "I want to understand something."

"Ask," he said.

"The family history feature in Richard Miller’s profile," she said. "The specific genetic marker pattern that made him a high-value addition to the phase two cohort. That feature is documented in three prior generations of his family."

"Yes," he said.

"His daughter has the same marker profile," she said. "Lower expression. But present."

He held very still.

"I didn’t know that," he said.

"It’s in the extended family history documentation that was submitted with his exception request," she said. "Did Max not read that section."

"Max read the clinical picture," he said. "The three-generation documentation was in a separate annex."

"I see," she said. She held the tablet. "The daughter’s profile means she should be monitored. Not treated. The expression level is too low to require intervention. But monitored."

"Sophie," he said.

"Yes," said Elena. "Sophie Miller. Fifteen."

He held her gaze.

"I’ll tell her," he said.

"Richard’s doctor should tell them both," said Elena. "I’ll flag it in the clinical notes." She held his gaze. "But I wanted you to know. Since you’re clearly paying attention."

"Yes," he said. "Thank you."

She held her tablet.

"I have three minutes now," she said.

"Go," he said.

She looked at him for one more moment.

"Sean Miller," she said.

"Elena Park," he said.

"The Kellerman submission," she said. "When the peer review comes back. I’d like to read the final version."

"I’ll send it," he said.

"Good," she said.

She walked back down the corridor.

He watched her go.

He held his phone.

He texted Max.

Richard Miller’s exception request. The extended family history annex. Did you read it.

Max replied in two minutes.

I read the primary clinical documentation. The annex was filed separately through the hospital’s research intake system. I didn’t have access to it. A pause. What’s in it.

Sophie has the same marker profile, said Sean. Low expression. Needs monitoring not treatment.

A pause from Max.

She doesn’t know, said Max.

No, said Sean. Richard’s doctor is going to flag it. Elena Park is adding it to the clinical notes today.

Elena Park, said Max. The principal investigator.

Yes, said Sean.

You met her, said Max.

In the corridor, said Sean.

Of course, said Max. Sean.

Yeah.

She identified you, said Max. She knew about the exception request framing.

Yes, said Sean.

She’s precise, said Max. And she reads everything.

Yes, said Sean. She does.

He put his phone in his pocket.

He thought about Sophie.

He thought about low expression and monitoring not treatment and a fifteen-year-old who had four questions saved and had organized them into categories.

He thought about telling her.

He thought about Richard’s doctor telling them both, which was correct and was how it should happen.

He thought about Elena Park flagging it in the clinical notes within the hour.

He thought about the specific quality of someone who had three minutes before their next patient consult and had used one of them to make sure he knew.

He thought about Ruth Albright on Thursday.

He thought about the page in his pocket.

He picked up the Ruth Albright file on his phone.

He kept reading.

The corridor around him doing its hospital Wednesday things.

Elena Park already in her next consult.